Quell Named CES 2019 Innovation Awards Honoree
January 08 2019 - 01:30PM
NeuroMetrix, Inc. (Nasdaq: NURO) announced that it has been named a
CES® 2019 Innovation Awards Honoree for Quell® 2.0 Wearable Pain
Relief Technology™ in the Fitness, Sports and Biotech product
category. The announcement was made during CES 2019, which runs
January 8-11, 2019 in Las Vegas, NV. The CES Innovation
Awards is an annual competition honoring outstanding design and
engineering in consumer technology products.
The new Quell 2.0 device launched in September of 2018 is
smarter, 20% more powerful and 50% smaller. The Quell app has been
totally redesigned to make it easier to use. Quell 2.0
will be the first wearable technology to utilize machine learning
to deliver unprecedented personalization for the treatment of
chronic pain. Additionally, the Quell app will include
Therapy Coach to help users achieve the best possible outcomes and
a new Intensive Therapy option. The Company announced additional
innovations that it expects to release later in
2019.
"We are proud to have been recognized by the CES community once
again for our commitment to bringing the latest digital therapeutic
and neurotechnology innovations to market," said Frank McGillin,
Senior Vice President and Chief Commercial Officer of
NeuroMetrix. "Chronic pain affects over 100 million
Americans, and in light of the opioid epidemic, chronic pain
sufferers are increasingly interested in drug free options that
allow them to get back to living life.”
The CES Innovation Awards are sponsored by the Consumer
Technology Association (CTA)™, owner and producer of CES, the
world’s largest and most influential technology event. CTA has been
recognizing achievements in product design and engineering since
1976.
NeuroMetrix’s Quell 2.0 is on display in the Innovation Awards
Showcase at CES. The complete list of CES 2019 Innovation
Honorees, including product descriptions and photos, can be found
at CES.tech/I nnovation.
About CESCES® is the world's gathering place
for all who thrive on the business of consumer technologies. It has
served as the proving ground for innovators and breakthrough
technologies for 50 years-the global stage where next-generation
innovations are introduced to the marketplace. As the largest
hands-on event of its kind, CES features all aspects of the
industry. Owned and produced by the Consumer Technology Association
(CTA)TM, it attracts the world's business leaders and pioneering
thinkers. Check out CES video highlights. Follow CES online at
CES.tech and on social.
About Consumer Technology Association Consumer
Technology Association (CTA)™ is the trade association representing
the $377 billion U.S. consumer technology industry, which supports
more than 15 million U.S. jobs. More than 2,200 companies – 80
percent are small businesses and startups; others are among the
world’s best-known brands – enjoy the benefits of CTA membership
including policy advocacy, market research, technical education,
industry promotion, standards development and the fostering of
business and strategic relationships. CTA also owns and produces
CES® – the world’s gathering place for all who thrive on the
business of consumer technologies. Profits from CES are reinvested
into CTA’s industry services.
About QuellQuell is an advanced, wearable
technology for treating chronic pain. It can be worn during the day
while active and at night while sleeping. Quell is drug-free and
has been cleared by the FDA for treatment of chronic pain without a
prescription. Quell has been shown in multiple clinical studies to
relieve chronic pain and, in a published study, 4 out of 5 users
reported improvement in chronic pain. Quell users can
personalize and manage therapy discreetly via the Quell app.
Quell also offers health tracking relevant to chronic pain
sufferers including pain, sleep, activity, and gait. Quell users
can synchronize their data with the Quell Health Cloud™, which
provides customized feedback and powers one of the world’s largest
chronic pain databases. Quell is available online and through
select retailers. Visit QuellRelief.com for more information.
About NeuroMetrixNeuroMetrix is a commercial
stage, innovation driven healthcare company combining
neurostimulation and digital medicine to address chronic health
conditions including chronic pain, sleep disorders, and diabetes.
The Company has two primary products. Quell is an over-the-counter
wearable therapeutic device for chronic pain. DPNCheck® is a rapid
point-of-care test for diabetic neuropathy which is the most common
long-term complication of Type 2 diabetes. For more information,
please visit http://www.neurometrix.com.
Source: NeuroMetrix, Inc.
NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief
Financial OfficerNeurometrix.ir@neurometrix.com
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Feb 2024 to Mar 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Mar 2023 to Mar 2024